Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug;102(2):241-8.
doi: 10.3945/ajcn.114.105072. Epub 2015 May 27.

Best (but oft-forgotten) practices: designing, analyzing, and reporting cluster randomized controlled trials

Affiliations
Review

Best (but oft-forgotten) practices: designing, analyzing, and reporting cluster randomized controlled trials

Andrew W Brown et al. Am J Clin Nutr. 2015 Aug.

Abstract

Cluster randomized controlled trials (cRCTs; also known as group randomized trials and community-randomized trials) are multilevel experiments in which units that are randomly assigned to experimental conditions are sets of grouped individuals, whereas outcomes are recorded at the individual level. In human cRCTs, clusters that are randomly assigned are typically families, classrooms, schools, worksites, or counties. With growing interest in community-based, public health, and policy interventions to reduce obesity or improve nutrition, the use of cRCTs has increased. Errors in the design, analysis, and interpretation of cRCTs are unfortunately all too common. This situation seems to stem in part from investigator confusion about how the unit of randomization affects causal inferences and the statistical procedures required for the valid estimation and testing of effects. In this article, we provide a brief introduction and overview of the importance of cRCTs and highlight and explain important considerations for the design, analysis, and reporting of cRCTs by using published examples.

Keywords: community randomized trial; group randomized trial; intraclass correlation coefficient; power analysis; reporting fidelity.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flow diagram to illustrate an example process for a cRCT. Each of the 4 panels from top to bottom highlights different levels of design and analysis considerations. White text boxes indicate design characteristics consistent with cRCTs, whereas black text boxes denote characteristics inconsistent with cRCTs (coupled with the unit being crossed out with an X). A crossed out design does not indicate an invalid study design per se but, rather, indicates a design that is beyond the scope of this article. “A” and “B” in the randomization row represent intervention allocations that would later be assigned to an intervention or control condition. Bubble 1: Non-cRCT design, such as a multisite RCT. Bubble 2: Observation of cluster-level outcomes makes the design no longer a multilevel design. Bubble 3: Analysis of individual-level observations as cluster-level outcomes ignores the multilevel nature of data and requires a different set of considerations for analyzing data than addressed herein. cRCT, cluster randomized controlled trial; RCT, randomized controlled trial.
FIGURE 2
FIGURE 2
Power curves of an example, 2-armed cRCT as a function of number of clusters and individuals within cluster. Curves show the power to detect a 0.25-unit difference (d) of the outcome with an SD of 1 (i.e., a standardized mean difference of 0.25), ICC of 0.02, and α = 0.05. The calculations assume an equal cluster size (m) and equal allocation (K ÷ 2) between treatments and use a t distribution. Although other values of ICC, d, and SDs may be used, the general shape of the lines will be qualitatively similar under different conditions, with greater K resulting in higher power than with lesser K for the same m. See Appendix A (Additional details: power analysis and sample-size calculation) for sample-size equations. ICC, intraclass correlation.
FIGURE 3
FIGURE 3
Simulation studies showed that ignoring ICC in analyses can affect the underlying type I error rate. Horizontal dotted lines demark the desired nominal α = 0.05 significance level. A: Grydeland et al. (15) observed an ICC of 0.02 but excluded it from their analyses. They reported a significant difference in the total sample and in a subanalysis of girls only. ICCs ≤0.02 may still affect the type I error. B: Bere et al. (18) did not report the ICC of their clusters; nor did they report an analysis that accounted for clustering. A reasonable range of ICCs from 0.001 to 0.05 were selected, and type I error rates were estimated from 10,000 independent simulated datasets per ICC and illustrated with 95% CIs. See Supplemental Material: Simulation for methods. ICC, intraclass correlation.
FIGURE 4
FIGURE 4
Ratings of compliance with specific criteria for the CONSORT for cRCTs. For each criterion, articles were assigned “Yes” if it was adequately reported; “Other” if it was partially, incompletely, unclearly, or implicitly reported; or “No” if it was not reported. Only items specific to cRCTs were rated. See Supplemental Material: Compliance for methods. CONSORT, Consolidated Standards of Reporting Trials; cRCT, cluster randomized controlled trial.

Similar articles

Cited by

References

    1. Teerenstra S, Moerbeek M, van Achterberg T, Pelzer BJ, Borm GF. Sample size calculations for 3-level cluster randomized trials. Clin Trials 2008;5:486–95. - PubMed
    1. Murray DM. Design and analysis of group-randomized trials. Oxford (United Kingdom): Oxford University Press; 1998.
    1. Sim LJ, Parker L, Kumanyika SK. Bridging the evidence gap in obesity prevention: a framework to inform decision making. National Academies Press; 2010. - PubMed
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG, Group C. Consort 2010 statement: extension to cluster randomised trials. BMJ 2012;345:e5661. - PubMed
    1. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol 2006;35:1292–300. - PubMed

APPENDIX A REFERENCES

    1. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86(2):420–8. - PubMed
    1. Turner RM, Prevost AT, Thompson SG. Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials. Stat Med 2004;23(8):1195–214. - PubMed
    1. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol 2006;35(5):1292–300. - PubMed
    1. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and statistics in medicine. Stat Med 2007;26(1):2–19. - PubMed
    1. Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: A review of recent methodological developments. Am J Public Health 2004;94(3):423–32. - PMC - PubMed

Publication types

MeSH terms